Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | MAOA | P21397 | 6/20 | 0.47 |
| ▸ | MAOB | P27338 | 6/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | TTR | P02766 | 2/20 | 0.46 |
| ▸ | SRC | P12931 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | DPP4 | P27487 | 1/20 | 0.42 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30458091 | 1.00 | MAPT (0.49) | MAPTKMT2AALDH1A1LMNAMEN1 | |
| SCHEMBL4938844 | 0.82 | MAPT (0.47) | MAPTKMT2AALDH1A1LMNAMEN1 | |
| SCHEMBL19243059 | 0.81 | MAOA (0.50) | MAPTKMT2AALDH1A1LMNAMEN1 | |
| SCHEMBL8546960 | 0.81 | TTR (0.53) | MAPTKMT2AALDH1A1LMNAMEN1 | |
| SCHEMBL2317083 | 0.81 | ALDH1A1 (0.49) | MAPTKMT2AALDH1A1LMNAMEN1 | |
| SCHEMBL30758635 | 0.81 | ALDH1A1 (0.49) | MAPTKMT2AALDH1A1LMNAMEN1 | |
| SCHEMBL11224876 | 0.80 | TTR (0.56) | MAPTKMT2AALDH1A1LMNAMEN1 | |
| SCHEMBL4294454 | 0.80 | ALDH1A1 (0.49) | MAPTKMT2AALDH1A1LMNAMEN1 | |
| SCHEMBL4233381 | 0.80 | TTR (0.50) | MAPTKMT2AALDH1A1LMNAMEN1 | |
| SCHEMBL2075852 | 0.80 | TTR (0.67) | MAPTKMT2AALDH1A1LMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250262205-A1 | DUAL MAGL AND FAAH INHIBITORS | LUNDBECK LA JOLLA RESEARCH CENTER, INC. (US) | 2025-08-21 | — | — | US | disclosed |
| US-12318383-B2 | Dual MAGL and FAAH inhibitors | LUNDBECK LA JOLLA RESEARCH CENTER, INC. (US) | 2025-06-03 | — | — | US | disclosed |
| EP-3634404-B1 | PYRAZOLE MAGL INHIBITORS | H LUNDBECK AS (DK) | 2024-11-20 | — | — | EP | disclosed |
| EP-3615515-B1 | PROPIONIC ACID DERIVATIVES AND METHODS OF USE THEREOF | AVIARA PHARMACEUTICALS INC (US) | 2024-09-25 | — | — | EP | disclosed |
| EP-4424683-A2 | DUAL MAGL AND FAAH INHIBITORS | Lundbeck La Jolla Research Center, Inc. (US) | 2024-09-04 | — | — | EP | disclosed |
| EP-3595665-B1 | DUAL MAGL AND FAAH INHIBITORS | LUNDBECK LA JOLLA RESEARCH CENTER INC (US) | 2024-08-28 | — | — | EP | disclosed |
| CN-118271288-A | Dual MAGL and FAAH inhibitors | 灵北拉荷亚研究中心公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-117736178-A | Dual MAGL and FAAH inhibitors | 灵北拉荷亚研究中心公司 | 2024-03-22 | — | — | CN | disclosed |
| EP-4335848-A2 | DUAL MAGL AND FAAH INHIBITORS | Lundbeck La Jolla Research Center, Inc. (US) | 2024-03-13 | — | — | EP | disclosed |
| CN-117510468-A | Dual MAGL and FAAH inhibitors | 灵北拉荷亚研究中心公司 | 2024-02-06 | — | — | CN | disclosed |
| EP-1532128-A1 | INHIBITORS OF HCV NS5B POLYMERASE | Pharmacia & Upjohn Company LLC (US) | 2005-05-25 | — | — | EP | disclosed |
| US-20040142980-A1 | Inhibitors of HCV NS5B polymerase | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | disclosed |
| WO-2004002977-A1 | INHIBITORS OF HCV NS5B POLYMERASE | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-01-08 | — | — | WO | disclosed |
| WO-2003037271-A2 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREFOR | MILLENNIUM PHARMACEUTICALS,INC. (US) | 2003-05-08 | — | — | WO | disclosed |
| EP-0746323-A4 | — | — | 1997-01-22 | — | — | EP | disclosed |
| EP-0746323-A1 | INHIBITORS OF PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C | MERCK & CO. INC. (US) | 1996-12-11 | — | — | EP | disclosed |
| WO-1995010286-A1 | INHIBITORS OF PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C | MERCK & CO., INC. (US) | 1995-04-20 | — | — | WO | disclosed |
| EP-0003427-B1 | PREPARATION OF M-(P-BROMOPHENOXY)BENZALDEHYDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-10-14 | — | — | EP | disclosed |
| US-4212829-A | Preparation of m-(p-bromophenoxy)benzaldehyde | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1980-07-15 | — | — | US | disclosed |
| EP-0003427-A1 | Preparation of m-(p-bromophenoxy)benzaldehyde | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1979-08-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142980-A1 | Inhibitors of HCV NS5B polymerase | POLRMT, POLR1E, CTDSP1 | MAPT 3583/4885KMT2A 2798/4885ALDH1A1 832/4885 |
| US-20250262205-A1 | DUAL MAGL AND FAAH INHIBITORS | FAAH, FAAH2, MAG | MAPT 812/4885KMT2A 2187/4885ALDH1A1 1891/4885 |
| US-12318383-B2 | Dual MAGL and FAAH inhibitors | FAAH, FAAH2, MAG | MAPT 812/4885KMT2A 2187/4885ALDH1A1 1891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.